InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Sidransky David, 董事. Officer active across 3 companies, notably Champions Oncology, INC.. In total, 4 disclosures have been published. Activity tracked since 15 October 2021. The latest transaction was filed on 12 October 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Sidransky David
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
46 股Common StockSEC:0001493152-23-002246:0
250 股Common StockSEC:0001213900-23-004541:0
8,333 股@ US$3.2137.6% 占其流量Common StockSEC:0001628280-22-026400:0
16,667 股@ US$1.5945.3% 占其流量Common StockSEC:0001628280-21-020221:0
4 条申报中的 4 条
About Sidransky David
David Sidransky is a Board Member of CHAMPIONS ONCOLOGY, INC. In this role, he participates in strategic decisions and governance of the company. Sidransky brings his expertise in oncology and business, helping to guide the company's direction. His experience is valuable for the board and for the development of the company's initiatives.
